Cargando…
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell death (RCD), also known as programmed cell death (PCD), has been widely reported to have numerous links to the progres...
Autores principales: | Liao, Minru, Qin, Rui, Huang, Wei, Zhu, Hong-Ping, Peng, Fu, Han, Bo, Liu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006445/ https://www.ncbi.nlm.nih.gov/pubmed/35414025 http://dx.doi.org/10.1186/s13045-022-01260-0 |
Ejemplares similares
-
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
por: Peng, Fu, et al.
Publicado: (2022) -
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
por: Qin, Rui, et al.
Publicado: (2022) -
Correction: Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
por: Qin, Rui, et al.
Publicado: (2022) -
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo
por: Zhang, Lan, et al.
Publicado: (2017) -
RCD+: Fast loop modeling server
por: López-Blanco, José Ramón, et al.
Publicado: (2016)